Fetzima and Breastfeeding
Although it is unknown if Fetzima (levomilnacipran) passes through breast milk in humans, it does pass through breast milk in rats. If the drug does pass through human breast milk, it could lead to serious side effects in an infant. Talk to your healthcare provider before taking Fetzima while breastfeeding to determine whether the benefits of the drug outweigh the risks to your child.
Can Breastfeeding Women Take Fetzima?
At this time, it is unknown if Fetzima™ (levomilnacipran) passes through human breast milk. Therefore, if you are nursing a child, talk with your healthcare provider before taking this medication.
More Information on Fetzima and Breastfeeding
No research has been done to see if Fetzima passes through breast milk in humans, or whether the medicine would harm a nursing child. In animal studies, the drug was shown to pass through the breast milk of rats.
Because many medicines pass through breast milk, and because there is the potential that Fetzima could cause serious side effects in a nursing child, the manufacturer recommends that women who are breastfeeding should decide whether or not to stop the medicine, taking into account the risks and benefits of stopping treatment. Because the potential risks to the nursing infant are not known, it may be best to avoid breastfeeding during Fetzima treatment until more information is available.
If your healthcare provider recommends breastfeeding while taking Fetzima, watch for any potential problems in your nursing child. Signs of problems could include:
- Difficulty feeding
- Unexplained crying.
Talking With Your Healthcare Provider
You should discuss breastfeeding and Fetzima use with your healthcare provider. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision that is right for you.